miR-671-5p mentioned in this study, promotes the migration and proliferation of human glioblastoma multiforme by targeting CDR1-AS, CDR1, and VSNL1 18, and suppresses the development of breast cancer via inhibiting epithelial-to-mesenchymal transition by targeting FOXM1 19. Here, CDR1 is linked to breast cancer.